Zobrazeno 1 - 10
of 371
pro vyhledávání: '"Morgan RL"'
Autor:
Ramakrishnan S, Janssens W, Burgel PR, Contoli M, Franssen FME, Greening NJ, Greulich T, Gyselinck I, Halner A, Huerta A, Morgan RL, Quint JK, Vanfleteren LEGW, Vermeersch K, Watz H, Bafadhel M
Publikováno v:
International Journal of COPD, Vol Volume 16, Pp 321-332 (2021)
Sanjay Ramakrishnan,1– 3 Wim Janssens,4 Pierre-Regis Burgel,5 Marco Contoli,6 Frits ME Franssen,7 Neil J Greening,8 Timm Greulich,9 Iwein Gyselinck,4 Andreas Halner,1 Arturo Huerta,10 Rebecca L Morgan,11 Jennifer K Quint,12 Lowie EGW Vanfleteren,13
Externí odkaz:
https://doaj.org/article/00905c9b33c346149df5aba069ad3b21
Autor:
Michel, Alissa M., Lichtenstein, Morgan RL, Faheem, Khadija, Harden, Erik, Hillyer, Grace, Beauchemin, Melissa P., Accordino, Melissa Kate, Hershman, Dawn L.
Publikováno v:
Journal of Clinical Oncology; 2024 Supplement 10, Vol. 20, p104-104, 34p
Autor:
Lichtenstein, Morgan RL, Raghunathan, Rohit R., Wei, Alexander Z, Gershman, Boris, Stein, Mark N., Hershman, Dawn L.
Publikováno v:
Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, p92-92, 235p
Autor:
Morgan RL Lichtenstein, Laura Levit, Caroline Schenkel, Margaret Kelsey Kirkwood, Michael J. Kelley, Josh Mailman, Allison Magnuson, Daniel P. Mirda, Divya Natesan, Lola A. Fashoyin-Aje, Dawn L. Hershman
Publikováno v:
Journal of Clinical Oncology. 40:385-385
385 Background: Since the onset of COVID-19, oncology practices across the U.S. have integrated telemedicine (TM) and remote patient monitoring (RPM) into routine care and clinical trials. However, the extent of provider experience and comfort with T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ca9fa5a4d69e2ccf17c37e5ac9733137
https://doi.org/10.1200/jco.2022.40.28_suppl.385
https://doi.org/10.1200/jco.2022.40.28_suppl.385
Autor:
Morgan RL Lichtenstein, Erik Harden, Nicole Collins, Khadija Faheem, Peter Campbell, Khilna Patel, Michelle K. Nguyen, Rachel Abramova, Melissa Parsons Beauchemin, Dawn L. Hershman
Publikováno v:
Journal of Clinical Oncology. 40:94-94
94 Background: During the COVID-19 pandemic, remote cancer care, and video communication in particular, has become increasingly common in the context of routine visits and clinical trials. Though this medium has the potential to augment patient-provi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5b4442e3de0381ea96e4f7e108362e23
https://doi.org/10.1200/jco.2022.40.28_suppl.094
https://doi.org/10.1200/jco.2022.40.28_suppl.094
Autor:
Beverly Moy, Emily Gorton, Ryan D. Nipp, Hang Lee, Elyse R. Park, Morgan Rl Lichtenstein, Bruce A. Chabner, Salome Kuchukhidze
Publikováno v:
The Oncologist
Financial barriers may discourage some patients with from participating in cancer clinical trials. This study sought to assess the effect of an equity intervention on the financial burden of clinical trial participants.
Background. The financial
Background. The financial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a998afab9bf3b51cfe8458e0e45cac6
https://doi.org/10.1634/theoncologist.2019-0146
https://doi.org/10.1634/theoncologist.2019-0146
Autor:
Morgan RL Lichtenstein, Khilna Patel, Peter Campbell, Michelle K. Nguyen, Erik Harden, John Spivack, Nicole Collins, Khadija Faheem, Melissa Parsons Beauchemin, Katherine D. Crew, Melissa Kate Accordino, Meghna S. Trivedi, Elena B. Elkin, Dawn L. Hershman
Publikováno v:
Journal of Clinical Oncology. 40:1592-1592
1592 Background: The past decade has seen a dramatic increase in the number of oral anti-cancer drug (OACD) approvals in the United States. Though polypharmacy and drug-drug interactions (DDIs) likely contribute to OACD toxicity, the prevalence of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::763248f2aaa6137f20264ae1e712aac2
https://doi.org/10.1200/jco.2022.40.16_suppl.1592
https://doi.org/10.1200/jco.2022.40.16_suppl.1592
Autor:
Rohit R. Raghunathan, Dawn L. Hershman, Elena B. Elkin, Morgan Rl Lichtenstein, Melissa Beauchemin, Jason D. Wright, Cynthia Law, Sahil D Doshi, Melissa Kate Accordino
Publikováno v:
Journal of Clinical Oncology. 39:6-6
6 Background: The past decade has seen a dramatic increase in the number of Food and Drug Administration approvals of oral anti-cancer drugs (OACDs). Most OACD prescriptions require coordination between payers and providers, which can delay drug rece
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::702ebd3f3c3c34097e44300226b50e2b
https://doi.org/10.1200/jco.2020.39.28_suppl.6
https://doi.org/10.1200/jco.2020.39.28_suppl.6
Autor:
Morgan Rl Lichtenstein, Elena B. Elkin, Melissa Beauchemin, Cynthia Law, Jason D. Wright, Dawn L. Hershman, Rohit R. Raghunathan, Melissa Kate Accordino, Sahil D Doshi
Publikováno v:
Journal of Clinical Oncology. 39:41-41
41 Background: Oral anti-cancer drugs (OACDs) have become increasingly prescribed over the last 10 years and require a significant amount of care coordination. Preliminary administrative database studies have shown that 10-15% of prescriptions are ne
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::84554dff3def19e6438d76668fc254d0
https://doi.org/10.1200/jco.2020.39.28_suppl.41
https://doi.org/10.1200/jco.2020.39.28_suppl.41
Autor:
Cynthia Law, Morgan Rl Lichtenstein, Melissa Beauchemin, Elena B. Elkin, Rohit R. Raghunathan, Jason D. Wright, Dawn L. Hershman, Melissa Kate Accordino, Sahil D Doshi
Publikováno v:
Journal of Clinical Oncology. 39:43-43
43 Background: Most oral anti-cancer drugs (OACD) prescriptions require extensive coordination between providers and payers, which can delay drug receipt. Specialty pharmacies are intended to facilitate communication between multiple entities to deli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dec0b440b2cc844d41d6b5951ed32b96
https://doi.org/10.1200/jco.2020.39.28_suppl.43
https://doi.org/10.1200/jco.2020.39.28_suppl.43